Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study

• 期刊论文

• 发表日期：

  2026年3月2日

• Ashish Sharma,
• Arshad M. Khanani,
• David Eichenbaum,
• David Boyer,
• Alexander Shaer,
• Trisha Ortiz,
• Humza Sulahria,
• Allyza Flores,
• Carl Regillo,
• Baruch D. Kuppermann,
• Anat Loewenstein,
• Francesco Bandello,
• Giuseppe Querques,
• Tomoko Ueda-Consolvo,
• Masaaki Ishida,
• Tomoko Nakamura,
• Atsushi Hayashi,
• Kotaro Tsuboi,
• Nilesh Kumar,
• Nikulaa Parachuri,
• Jay Sheth,
• Chitaranjan Mishra,
• Debdulal Chakraborty,
• Alay Banker,
• Kourous A. Rezaei,
• Peter K. Kaiser,
• Frank G. Holz,
• Sobha Sivaprasad,
• Şengül Özdek,
• Kodjikian Laurent,
• Alper Bilgic,
• Paolo Lanzetta,
• Valentina Sarao,
• Caroline Baumal,
• Nancy Holekamp,
• Taiji Sakamoto,
• Adnan Tufail,
• Nicolas Yannuzzi,
• Jayanth Sridhar,
• Giulia Corradetti,
• Aleksandra Rachitskaya,
• Tunde Peto,
• Maximilian W. M. Wintergerst,
• Barbara Parolini,
• Quan Dong Nguyen,
• Diana V. Do,
• Pearse A. Keane,
• Tarek Hassan,
• Dilraj S. Grewal,
• Francesc March,
• Martin S. Spitzer,
• Khalil G. Falavarjani,
• Martin S. Zinkernagel,
• Christopher Seungkyu Lee,
• Judy E. Kim,
• Se Joon Woo,
• Luke Nicholson,
• Clara Vazquez-Alfageme,
• Taku Wakabayashi